- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
Total 586 results
-
Capital Medical UniversityTerminatedCancer | Mesothelioma, MalignantChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck Squamous Cell CarcinomaChina
-
Sun Yat-sen UniversitySecond Affiliated Hospital of Guangzhou Medical UniversityCompletedCarcinoma, Hepatocellular | Liver Neoplasms | Sintilimab | Portal Vein Tumor ThrombusChina
-
DNAtrix, Inc.Merck Sharp & Dohme LLCCompletedNervous System Diseases | Glioma | Glioblastoma | Neuroectodermal Tumors | Brain Cancer | Gliosarcoma | Brain Neoplasm | Malignant Brain Tumor | Neoplasm, Neuroepithelial | Neoplasm by Histologic Type | Neoplasm, Nerve TissueUnited States, Canada
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownEsophageal Neoplasms | Esophageal DiseasesChina
-
Sun Yat-sen UniversityWithdrawn
-
Ruijin HospitalNot yet recruitingNK-T-Cell Lymphoma, ExtranodalChina
-
TILT Biotherapeutics Ltd.RecruitingMelanoma | Head and Neck Squamous Cell CarcinomaUnited States, Finland
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Childhood Ependymoma | Advanced Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Puerto Rico
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
West China HospitalRecruitingImmunotherapy | SBRT | Stage IV HCCChina
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; The First Affiliated Hospital... and other collaboratorsWithdrawnHepatocellular CarcinomaChina
-
Zhangfa SongNot yet recruitingMetastatic Colorectal Cancer | MSSChina
-
Zhejiang UniversityRecruiting
-
Capital Medical UniversityCompletedCancer | Metastatic Cancer | Abdominal Cancer | Pelvic Cancer | Liver Metastases | Peritoneal MetastasesChina
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumourAustralia
-
Dong WangUnknownNon-squamous Non-small Cell Lung CancerChina
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumorAustralia
-
Shanghai Junshi Bioscience Co., Ltd.UnknownAdvanced Melanoma | Kidney Cancer Stage IvChina
-
Shanghai Junshi Bioscience Co., Ltd.UnknownBladder Urothelial CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.UnknownMetastatic Melanoma | Advanced MelanomaChina
-
Mingzhi ZhangUnknownNK/T Cell LymphomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Livzon Pharmaceutical Group Inc.Completed
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell LymphomaUnited States
-
Sun Yat-sen UniversityRecruitingColorectal Cancer | Liver MetastasesChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Beijing Friendship HospitalCompleted
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdRecruitingAdvanced Non-small Cell Lung CancerChina
-
Chinese PLA General HospitalCompleted
-
Qilu Hospital of Shandong UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruitingSmall Cell Lung Cancer
-
Roswell Park Cancer InstituteWithdrawnMalignant Solid Neoplasm | Lung Adenocarcinoma | Colorectal Carcinoma | Pancreatic CarcinomaUnited States
-
Chinese PLA General HospitalRecruitingColorectal Neoplasms | Colorectal Cancer | Microsatellite Stable Colorectal Carcinoma | RAS MutationChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingColorectal Cancer | ImmunotherapyChina
-
Beijing Friendship HospitalChanghai Hospital; Peking Union Medical College Hospital; Peking University Cancer...Not yet recruitingLocally Advanced Rectal CancerChina
-
Hunan Cancer HospitalCompletedAnti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaChina
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
Han weidongUnknownMalignancies MultipleChina
-
Shanghai Henlius BiotechCompleted
-
Shi MingWithdrawnHepatocellular CarcinomaChina
-
Shanghai Henlius BiotechSuspendedColorectal Cancer MetastaticChina
-
Waterstone Hanxbio Pty LtdRecruitingRelapsed/Refractory LymphomaChina
-
Sun Yat-sen UniversityRecruitingRecurrent Nasopharyngeal CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.Active, not recruitingAdvanced MalignanciesUnited States
-
Shanghai Junshi Bioscience Co., Ltd.UnknownMelanoma | Urological CancerChina
-
Peking UniversityUnknown
-
Shanghai Henlius BiotechNot yet recruiting
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's Hospital and other collaboratorsNot yet recruitingNasopharyngeal Carcinoma | Neoadjuvant Therapy | PD-1 Inhibitor
-
Liang PengGuangzhou Virotech Pharmaceutical Co., Ltd.UnknownAdvanced/Metastatic Hepatocellular Carcinoma